The role of acetyl-CoA carboxylase enzymes in fatty liver disease and cancer [ 2019 - ]

Research Grant

Brief description Non-alcoholic fatty liver disease (NAFLD) affects more than 5 million Australians and is an unmet medical need with no approved therapies. It is of vital importance to target NAFLD early before it progresses to cirrhosis, liver cancer, or liver failure. This project aims to reverse NAFLD progression by targeting enzymes involved in liver fat synthesis. The outcomes of this research will guide future drug development.

Funding Amount $564,999.00

Funding Scheme Project Grants

Notes Standard Project Grant